PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16624439-7	2006	Addition of the aldose reductase inhibitor SNK-860 dose-dependently decreased the intracellular sorbitol concentration in HUVECs incubated in high glucose medium, and also significantly suppressed the increases in fragmented DNA, caspase-3 activity and 8-OHdG by conditioning with high glucose medium.	Sorbitol	96-104	polo like kinase 2	Homo sapiens	43-46	
12039395-0	2002	Fidarestat (SNK-860), a potent aldose reductase inhibitor, normalizes the elevated sorbitol accumulation in erythrocytes of diabetic patients.	Sorbitol	83-91	polo like kinase 2	Homo sapiens	12-15	
15531183-0	2004	Erythrocytic sorbitol contents in diabetic patients correlate with blood aldose reductase protein contents and plasma glucose levels, and are normalized by the potent aldose reductase inhibitor fidarestat (SNK-860).	Sorbitol	13-21	polo like kinase 2	Homo sapiens	206-209	
7648800-4	1995	The addition of 10 mumol l-1 SNK normalized the increased sorbitol levels in neutrophils exposed to 40 mmol l-1 glucose and improved, but did not normalize, the decrease in CL induced by 40 mmol l-1 glucose (p < 0.001).	Sorbitol	58-66	polo like kinase 2	Homo sapiens	29-32